Disrupted in schizophrenia 1: building brains and memories

Trends in Molecular Medicine

Volumn 12, Issue 6, 2006, Pages 255-261

  Porteous, David J ^a   Millar, J Kirsty ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; NEUROPEPTIDE; OLIGOPEPTIDE; PHOSPHODIESTERASE IV; PROTEIN; PROTEIN DISRUPTED IN SCHIZOPHRENIA 1; PROTEIN DISRUPTED IN SCHIZOPHRENIA 2; RNA; UNCLASSIFIED DRUG;

BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; CHROMOSOME 11; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 11; COGNITIVE DEFECT; DISEASE PREDISPOSITION; DISRUPTED IN SCHIZOPHRENIA 1 GENE; DRUG RESEARCH; DRUG TARGETING; EXPERIMENTAL MODEL; GENE; GENE DELETION; GENE DISRUPTION; GENE DUPLICATION; GENE EXPRESSION; GENE INSERTION; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENE TRANSLOCATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; MEMORY; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; POPULATION RESEARCH; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSYCHOSIS; REVIEW; RISK FACTOR; RNA TRANSCRIPTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; AMINO ACID SEQUENCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRAIN; CARRIER PROTEINS; CYCLIC AMP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMORY DISORDERS; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PHOSPHODIESTERASE INHIBITORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; SCHIZOPHRENIA;

EID: 33745048992     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.04.009     Document Type: Review

References (60)

1. Jamison K.R. Touched with Fire: Manic Depressive Illness and the Artistic Temperament (1994), Simon & Schuster
2. In: Frith C., and Johnstone E.C. (Eds). Schizophrenia: A very short introduction (2003), Oxford University Press
3. Lopez A.D., and Murray C.C.J.L. The global burden of disease. Nat. Med. 4 (1998) 1241-1243
4. In: Wolpert L. (Ed). Malignant Sadness: The Anatomy of Depression (1999), Faber & Faber
5. Laing R.D. The Divided Self: A Study of Sanity and Madness (1960), Tavistock Publications
6. In: Gottesman I.I. (Ed). Schizophrenia Genesis: The Origins of Madness (1991), W.H. Freeman & Co
7. Millar J.K., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9 (2000) 1415-1423
8. Millar J.K., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signalling. Science 310 (2005) 1187-1190
9. Kamiya A., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 7 (2005) 1167-1178
10. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
11. Jacobs P.A., et al. A cytogenetic survey of 11,680 new born infants. Ann. Hum. Genet. 37 (1974) 359-376
12. Conrad D.F., et al. A high-resolution survey of deletion polymorphism in the human genome. Nat. Genet. 38 (2005) 75-81
13. Hinds D.A., et al. Common deletions and SNPs are a linkage disequilibrium in the human genome. Nat. Genet. 38 (2005) 82-85
14. McCarroll S.A., et al. Common deletion polymorphisms in the human genome. Nat. Genet. 38 (2006) 86-92
15. Pickard B.S., et al. Cytogenetics and gene discovery in psychiatric disorders. Pharmacogenomics J. 5 (2005) 81-88
16. Sebat J., et al. Large-scale copy number polymorphism in the human genome. Science 305 (2004) 525-528
17. Jobanputra V., et al. Application of ROMA (representational oligonucleotide microarray analysis) to patients with cytogenetic rearrangements. Genet. Med. 7 (2005) 111-118
18. St Clair D., et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336 (1990) 13-16
19. Blackwood D.H., et al. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69 (2001) 428-433
20. Thomson, P.A. et al. (2005a) Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol. Psychiatry 10, 657-668
21. Hamshere M.L., et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry 62 (2005) 1081-1088
22. Devon R.S., et al. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr. Genet. 11 (2001) 71-78
23. Callicott J.H., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8627-8632
24. Thomson, P.A. et al. (2005b) Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci. Lett. 389, 41-45
25. Hennah W., et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12 (2003) 3151-3159
26. Hennah W., et al. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol. Psychiatry 10 (2005) 1097-1103
27. Hodgkinson C.A., et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 75 (2004) 862-872
28. Cannon T.D., et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 62 (2005) 1205-1213
29. Burdick K.E., et al. DISC1 and neurocognitive function in schizophrenia. Neuroreport 16 (2005) 1399-1402
30. Cohen J., et al. Multiple rate alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-871
31. Taylor M.S., et al. Evolutionary constraints on the Disrupted in Schizophrenia locus. Genomics 81 (2003) 67-77
32. Ozeki Y., et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 289-294
33. Miyoshi K., et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 8 (2003) 685-694
34. Schurov I.L., et al. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 9 (2004) 1100-1110
35. James, R. et al. Disrupted in Schizophrenia 1 (DISC1) is a multi-compartmentalised protein that predominantly localises to mitochondria. Molecular and Cellular Neuroscience 26: 112-22
36. Millar J.K., et al. DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness. Ann. Med. 36 (2004) 367-378
37. Morris J.A., et al. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 12 (2003) 1591-1608
38. Millar J.K., et al. Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem. Biophys. Res. Commun. 311 (2003) 1019-1025
39. Brandon N.J., et al. Disrupted In Schizophrenia 1 (DISC1) and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol. Cell. Neurosci. 25 (2004) 42-55
40. Miyoshi K., et al. DISC1 localizes to the centrosome by binding to kendrin. Biochem. Biophys. Res. Commun. 317 (2004) 1195-1199
41. Ogawa F., et al. A functional link between Disrupted-In-Schizophrenia 1 and the eukaryotic translation initiation factor 3. Biochem. Biophys. Res. Commun. 338 (2005) 771-776
42. Hirotsune S., et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet. 19 (1998) 333-339
43. Sasaki S., et al. Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. Mol. Cell. Biol. 25 (2005) 7812-7827
44. Sawamura N., et al. A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance-alcohol abuse. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1187-1192
45. Davis R.L., et al. The cyclic AMP system and Drosophila learning. Mol. Cell. Biochem. 149-150 (1995) 271-278
46. O'Donnell J.M., and Zhang H.T. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol. Sci. 25 (2004) 158-163
47. Zhang H.T., et al. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27 (2002) 587-595
48. Alberini C.M., et al. A molecular switch for the consolidation of long-term memory: cAMP-inducible gene expression. Ann. N. Y. Acad. Sci. 758 (1995) 261-286
49. Duman R.S. Synaptic plasticity and mood disorders. Mol. Psychiatry 7 (2002) S29-S34
50. Hennah W., et al. Two biologically interacting genes, DISC1 and NDE1, associate with schizophrenia and visual working memory functions. Am. J. Med. Genet. 138B (2005) 123
51. Johnstone E.C., et al. What does the Edinburgh high-risk study tell us about schizophrenia?. Am. J. Med. Genet. 114 (2002) 906-912
52. Koike H., et al. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3693-3697
53. Feldman A.M., and McNamara D.M. Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease. Clin. Cardiol. 25 (2002) 256-262
54. Smith V.B., and Spina D. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation. Curr. Opin. Investig. Drugs 6 (2005) 1136-1141
55. Rose G.M., et al. Phosphodiesterase inhibitors for cognitive enhancement. Curr. Pharm. Des. 11 (2005) 3329-3334
56. Hayashi M.A., et al. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3828-3833
57. Camargo A.C., et al. Brain endo-oligopeptidase A, a putative enkephalin converting enzyme. J. Neurochem. 48 (1987) 1258-1263
58. Oliveira E.S., et al. Localization of endo-oligopeptidase (EC 3.4.22.19) in the rat nervous tissue. J. Neurochem. 55 (1990) 1114-1121
59. Hayashi M.A., et al. Expression of endo-oligopeptidase A in the rat central nervous system: a non-radioactive in situ hybridization study. Brain Res. Mol. Brain Res. 89 (2001) 86-93
60. Craddock N., et al. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 32 (2006) 9-16